Used in pharmaceutical research as a potent and selective inhibitor of specific kinase enzymes involved in inflammatory and immune-mediated diseases. Shows promise in the development of treatments for autoimmune conditions such as rheumatoid arthritis and psoriasis due to its ability to modulate signaling pathways that control cytokine production and immune cell activation. Its structure allows for high binding affinity and improved pharmacokinetic properties, making it suitable for oral administration in preclinical studies. Also serves as a lead compound for optimizing new anti-inflammatory agents with enhanced efficacy and reduced side effects.